OxyContin maker Purdue Pharma reaches $8.34 bil settlement, pleads guilty for role in opioid case

The settlement with the DOJ ends years of litigation against the now bankrupt maker of OxyContin

0:00 / 0:00

15 seconds

15 seconds

Published: October 21, 2020 11:23am

Updated: October 21, 2020 6:12pm

The Department of Justice reached an $8.34 billion settlement with Purdue Pharma, the maker of OxyContin, said the department on Wednesday.

The company, now bankrupt, will be required to turn over future profits to cities and states that accuse it of playing a meaningful role in facilitating the opioid crisis. Purdue has also agreed to plead guilty to three counts pertaining to payments to healthcare providers. 



Wednesday’s announcement puts an end to the years-long case that investigated the marketing and distribution of the powerful painkiller. 

Despite the fact that the current assets of Purdue Pharma fall well short of $8 billion, the Sackler family, who own the company, will contribute $225 million to resolve separate civil claims and the company will pay $225 million to the federal government.

Today’s deal does not prevent the government from filing suits against the owners of Purdue in the future. 

Unlock unlimited access

  • No Ads Within Stories
  • No Autoplay Videos
  • VIP access to exclusive Just the News newsmaker events hosted by John Solomon and his team.
  • Support the investigative reporting and honest news presentation you've come to enjoy from Just the News.
  • Just the News Spotlight

    Support Just the News